Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) FCF Margin (2024)

Zentalis Pharmaceuticals (ZNTL) has 1 years of FCF Margin data on record, last reported at 147.78% in Q4 2024.

  • For Q4 2024, FCF Margin changed N/A year-over-year to 147.78%; the TTM value through Sep 2025 reached 498.82%, down 7439.0%, while the annual FY2024 figure was 253.74%, N/A changed from the prior year.
  • FCF Margin reached 147.78% in Q4 2024 per ZNTL's latest filing, down from 128.24% in the prior quarter.
  • Across five years, FCF Margin topped out at 128.24% in Q1 2024 and bottomed at 147.78% in Q4 2024.